GEHC GE HealthCare Technologies Inc. Projected Price to Earnings

GE HealthCare demonstrates exemplary R&D transparency and management discipline following its spin-off from the conglomerate. The forward P/E dynamics on the GURU.Markets daily chart show that the value of 15.00 expresses the metric level. Revenues are based on B2B supplies of complex imaging and services, while high liquidity and steady demand for CT scanners guarantee stable funding for all obligations.

GEHC - gehealthcare.com Market Cap to Projected Earnings over the range 04/28/2023 - 11/14/2026

Financial and market metric breakdowns for gehealthcare.com (GEHC)

- stock value and consensus price forecast:

Price Chart GE HealthCare Inc.|GEHC - Analyst Median Target

- market capitalization data:

Market Valuation GE HealthCare Technologies Inc.|GEHC - Aggregate Business Value

- issuer book value statistics:

Book Value per Share GE HealthCare|GEHC - Book Valuation of Business|Market Capitalization to Book Value Ratio gehealthcare.com|GEHC - Cumulative Company Assets

- debt and solvency information:

- earnings and market ratios statistics:

GEHC - Net Financial Result|Projected Future Earnings GE HealthCare|GEHC - Price to Earnings Ratio|Forward P/E Multiple GE HealthCare Inc.|GEHC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization GE HealthCare Inc.|GEHC - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months GE HealthCare|GEHC - Earnings per share for the trailing year|Quarterly EPS earnings growth gehealthcare.com|GEHC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year GE HealthCare

- revenue and sales proceeds data:

GEHC - Company Total Sales Volume|Company Future Sales Volume GE HealthCare Technologies Inc.|GEHC - P/S Multiple|Forward P/S Multiple GE HealthCare Technologies

Fundamental company analysis:gehealthcare.com

GE HealthCare possesses significant pricing power due to the ecosystem lock-in of customers to its high-cost equipment. The company's forward P/E reflects the asset's market value relative to projected earnings for the coming period. This indicator is calculated by dividing the current share price by the expected earnings per share. This allows for an assessment of the premium investors are paying for future cash flows. Low values signal that the business is undervalued, given its sustainable margins.

Competitors of GE HealthCare (GEHC)

Projected Price to Earnings ABT (Abbott)|Market Cap to Future Earnings Ratio TMO|Forward P/E Multiple MTD (mt.com)|Market Cap to Projected Earnings Waters Corporation (WAT)|Bio-Techne Corp - Forward P/E Multiple|Market Cap to Projected Earnings Bruker BRKR|AZTA: Forward P/E Multiple|Projected Price to Earnings Varex Imaging|Projected Price to Earnings SMLR|BFLY: Future Price to Earnings Multiple|Future Price to Earnings Mesa Laboratories Inc (MLAB)|QSI - Projected Price to Earnings Ratio|Forward P/E Multiple NNOX (nanox.vision)|Quanterix Corp (QTRX) - Projected Price to Earnings Ratio|908 Devices - Forward P/E Multiple|capsovision.com (CV) - Projected Price to Earnings|MXCT: Forward P/E Multiple|RPID - Market Cap to Projected Earnings|SEER (Seer Bio) - Forward P/E Multiple|Projected Price to Earnings Hyperfine Corp (HYPR)|Forward P/E Multiple FONR|Future Price to Earnings DXR (Daxor Corp.)|Future Price to Earnings Spectral AI, Inc. MDAI|Organovo Holdings, Inc. - Future Price to Earnings|ACON: Projected Price to Earnings|Future Price to Earnings Multiple AKYA (akoyabio.com)|THMO: Forward P/E Multiple|Projected Price to Earnings Ratio Talis Biomedical Corp (TLIS)|Future Price to Earnings t2biosystems.com